Massachusetts General Bright Hospital announces delays in certain procedures requiring IV fluids

The hospital is conserving its supply of IV fluids for patients needing immediate care. 

By Hannah Woods

In the aftermath of Hurricane Helene, Massachusetts General Bright Hospital announced delays for some non-emergency procedures due to a national shortage of IV fluids on Sunday. 

One main supplier of IV fluids was closed due to damage from the hurricane. The Baxter International plant in North Cove, North Carolina supplies a large amount of the nation’s IV fluids, but experienced major flooding. About 60% of IV fluids in U.S. hospitals are produced by the plant, Mass General was receiving 40% of its supply until the plant’s closure.

Every type of IV fluid is impacted by the shortage and it has become difficult to find other suitable products in place of IV fluids. While the hospital stated a timeline following the shortage, the situation remains unpredictable. 

The Food and Drug Administration (FDA) continues to issue updates on the 2024 hurricane season. Last Friday, the FDA added three IV fluids to the drug shortage database including Dextrose 70% IV solution, Lactated Ringers IV solution and Peritoneal Dialysis Solution. The FDA additionally released “Temporary Policies for Compounding Certain Drug Products,” an immediately-in-effect guidance. According to the FDA, compounding is a licensed practice which “combines, mixes, or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.” 

Although compounded drugs allow licensed pharmacists, physicians and facilities flexibility during the shortage of IV fluids, there are still many risks.